MedPath

Centralized Lung Cancer Screening Engagement in At-Risk Populations

Not Applicable
Not yet recruiting
Conditions
Lung Cancer Screening
Registration Number
NCT07216144
Lead Sponsor
Weill Medical College of Cornell University
Brief Summary

This study will assess the impact of centralized outreach on lung cancer screening completion among individuals served by Federally Qualified Health Centers.

Detailed Description

This will be a two-arm, parallel, pragmatic randomized controlled trial (RCT) to evaluate the effectiveness of a centralized patient outreach strategy in increasing lung cancer screening (LCS) completion among populations served by Federally Qualified Health Centers (FQHCs). This study will randomize individuals potentially eligible for LCS (50-80 years, current or past smokers) to receive centralized patient outreach in addition to usual care (outreach arm) and usual care alone (usual care arm). Individuals assigned to the outreach arm will receive centralized patient outreach from the Lung screening team through a letter followed by up to three attempts of telephone contact. Individuals assigned to the usual care arm will not receive any contact during the study period and the referral for LCS will be made at the treating physician's discretion.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
2000
Inclusion Criteria
  • Adults aged 50 to 80 years
  • Current or past smokers
  • Individuals without a recorded LDCT scan within the past year
  • Individuals without a prior lung cancer diagnosis
  • Active patients of Ryan Health
  • Individuals with a mailing address in the New York City area and a phone number on file
Exclusion Criteria
  • Individuals aged less than 50 or above 80 years
  • Individuals without smoking history
  • Individuals with a recorded LDCT scan within the past year
  • Individuals with a prior lung cancer diagnosis
  • Individuals without a mailing address in the New York City area or a phone number on file
  • Individuals served by one of Ryan Health clinics where the centralized patient outreach was developed

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Proportion of individuals completing low-dose CT (LDCT) within 15 months of randomization.Within 15 months of randomization
Secondary Outcome Measures
NameTimeMethod
Average costs of implementing centralized outreach per individualWithin 15 months of randomization
LDCT scan findings: Lung Imaging Reporting and Data System (Lung-RADS)Within 15 months of randomization

Proportion of individuals with Lung-RADS 1, 2, 3, and 4

LDCT incident findingsWithin 15 months of randomization

Proportion of individuals with incident findings on LDCT (including moderate to severe coronary artery calcification, lung-mediastinal findings, moderate to severe emphysema, and abdominal findings)

Follow-up careWithin 6 months after screening

Proportion of individuals receiving a biopsy or lung cancer treatment

Trial Locations

Locations (1)

Weill Cornell Medicine

🇺🇸

New York, New York, United States

Weill Cornell Medicine
🇺🇸New York, New York, United States
Bradley B Pua, MD
Contact
646-962-5757
brp9018@med.cornell.edu
Jialin Mao, MD, PhD
Contact
6469628030
jim2012@med.cornell.edu

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.